Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TherapeuticsMD, Inc. | CEO, Director | Restricted Stock Units | 747K | $2.72M | $3.64 | Jul 1, 2021 | Direct |
TherapeuticsMD, Inc. | CEO, Director | Performance Stock Units | 1.49M | Jul 1, 2021 | Direct | ||
ZyVersa Therapeutics, Inc. | Director | Stock Options | 132 | May 24, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZVSA | ZyVersa Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | Jul 18, 2024 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 3 | $0 | 4 | Dec 14, 2022 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Director |
TXMD | TherapeuticsMD, Inc. | Jul 1, 2021 | 2 | $0 | 4 | Jul 2, 2021 | CEO, Director |
TXMD | TherapeuticsMD, Inc. | May 10, 2021 | 3 | -$70.4K | 4 | May 12, 2021 | CEO, Director |